Hollings Renton, Director at CEPHEID (CPHD), sold 15,000 shares at $43.13 ($648K) on 2012-02-06, disclosed to the SEC on 2012-02-06.
Open-market sale of $648k CPHD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.20 | 12,500 | $540K | 83.4% |
| 2 | $43.13 | 2,500 | $108K | 16.6% |
| Total | $43.19 avg | 15,000 | $648K | 100% |
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |